Treatment for HIV-related inflammation.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000627:therapeutic use*; D007249:Inflammation / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D015215:Zidovudine / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000998:Antiviral Agents; D015215:Zidovudine; D006886:Hydroxychloroquine